Viking Therapeutics, Inc. (VKTX)
33.86
-0.52
(-1.51%)
USD |
NASDAQ |
Aug 27, 16:00
34.02
+0.16
(+0.47%)
After-Hours: 05:22
Viking Therapeutics Total Return Level : 33.86 for Aug. 27, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| August 27, 2026 | 33.86 |
| August 26, 2026 | 34.38 |
| August 25, 2026 | 34.17 |
| August 24, 2026 | 33.23 |
| August 21, 2026 | 33.89 |
| August 20, 2026 | 34.36 |
| August 19, 2026 | 35.98 |
| August 18, 2026 | 33.37 |
| August 17, 2026 | 33.63 |
| August 14, 2026 | 33.19 |
| August 13, 2026 | 32.94 |
| August 12, 2026 | 34.02 |
| August 11, 2026 | 33.80 |
| August 10, 2026 | 34.44 |
| August 07, 2026 | 34.26 |
| August 06, 2026 | 33.30 |
| August 05, 2026 | 33.51 |
| August 04, 2026 | 32.94 |
| August 03, 2026 | 32.61 |
| July 31, 2026 | 31.74 |
| July 30, 2026 | 33.11 |
| July 29, 2026 | 33.43 |
| July 28, 2026 | 33.86 |
| July 27, 2026 | 34.87 |
| July 24, 2026 | 34.79 |
| Date | Value |
|---|---|
| July 23, 2026 | 35.39 |
| July 22, 2026 | 37.31 |
| July 21, 2026 | 37.95 |
| July 20, 2026 | 36.38 |
| July 17, 2026 | 37.08 |
| July 16, 2026 | 36.37 |
| July 15, 2026 | 37.81 |
| July 14, 2026 | 37.97 |
| July 13, 2026 | 38.12 |
| July 10, 2026 | 38.86 |
| July 09, 2026 | 41.14 |
| July 08, 2026 | 39.96 |
| July 07, 2026 | 42.13 |
| July 06, 2026 | 38.71 |
| July 02, 2026 | 37.44 |
| July 01, 2026 | 37.48 |
| June 30, 2026 | 39.01 |
| June 29, 2026 | 39.54 |
| June 26, 2026 | 38.04 |
| June 25, 2026 | 36.99 |
| June 24, 2026 | 37.87 |
| June 23, 2026 | 34.81 |
| June 22, 2026 | 32.37 |
| June 18, 2026 | 30.38 |
| June 17, 2026 | 30.29 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Vertex Pharmaceuticals, Inc. | 547.55 |
| Eli Lilly & Co. | 3107.50 |
| Regeneron Pharmaceuticals, Inc. | 815.20 |
| Skye Bioscience, Inc. | 1.95 |
| Eledon Pharmaceuticals, Inc. | 3.32 |